Kelyniam Global Announces Q3 2025 Financial Results [Yahoo! Finance]
KELYNIAM GLOBAL INC (KLYG)
Company Research
Source: Yahoo! Finance
Q3 2025 Financial Highlights (Compared to Q3 2024) Year-to-date revenue of $2,186,491, compared to $2,492,607, a decrease of 12.3%. Gross profit of $1,695,496, compared to $1,956,714, a decrease of 13.3%, primarily due to the revenue headwinds offset by stable material costs. Operating loss of $(162,373), compared to operating income of $273,248, reflecting increased investments in sales support and regulatory costs associated with the new Vestakeep® product. "Sales have faced headwinds this year from a slow distributor ramp-up and temporary market share shifts, but through Q3, we're steadily catching up to 2024 levels and building a stronger foundation for sustainable growth," said Ross Bjella, CEO of Kelyniam Global . "The cranial implant sector remains robust, with competitors with overall market projections showing expansion from $1.43 billion in 2024 to over $1.5 billion in 2025. We're capitalizing on this by aggressively adding distributors in untapped markets, where we
Show less
Read more
Impact Snapshot
Event Time:
KLYG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KLYG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KLYG alerts
High impacting KELYNIAM GLOBAL INC news events
Weekly update
A roundup of the hottest topics
KLYG
News
- Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants [Yahoo! Finance]Yahoo! Finance
- Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial ImplantsGlobeNewswire
- Kelyniam Global Announces Q3 2025 Financial ResultsPR Newswire
- Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products [Yahoo! Finance]Yahoo! Finance
- Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline ProductsGlobeNewswire